Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) In The Treatment Of Child And Adolescent Outpatients With Major Depressive Disorder
Clinical trial NCT00619619 · COMPLETED
Trial details
- NCT number
- NCT00619619
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-02-01
- Primary completion
- 2009-11-01
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.